PRCSG Training Webinar: Budget for Industry Sponsored Studies

Slides:



Advertisements
Similar presentations
Tips to a Successful Monitoring Visit
Advertisements

Chicken Soup for the Busy Coordinator
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
Clinical Trials Budgeting, Part 2. Agenda Overview of clinical trials fund setup by OSP/OSPA Invoicing for study start-up fees Invoicing for per patient/milestone.
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
KUMC Research Institute
HIV Clinical Trials Janice Price, M.Ed, RN HIV Clinical Research Program Coordinator Swedish Medical Center Seattle, WA USA.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Determining % Effort for Clinical Trial Kathy Price, RN, MBA Manager, GI Clinical Research.
KUMC Research Institute
Clinical Trial Finances: Juggling the Skills of the Research Coordinator.
1 Budgeting for Clinical Trials from a Site Perspective ©CTNBP 2010 Kathy Kioussopoulos, RN, BSN CTNBP SCAC 27 September 2010 Kathy Kioussopoulos, RN,
PRE-AWARD PAPERWORK FOR CLINICAL TRIALS SERIES 4, SESSION 8 OCTOBER 28, 2014 Applicants and Administrators Pre-Award Luncheon Series.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Clinical Trial Infrastructure in Centres Lillian L. Siu Princess Margaret Hospital.
Coordinator University Clinical Research Pharmacy Investigational Drug Service (IDS) Marjorie Shaw Phillips, MS, RPh, FASHP Clinical Research Pharmacist.
Yesterday, today, and tomorrow
CBER Review Considerations on Source Plasma Vaccination Programs Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Feldman 20 February Clinical Trials Design Martha A. Feldman, RAC Drug & Device Development Co., Inc. P.O. Box 3515 Redmond, WA USA
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Budget Development Presented by: Jean Mercer Associate Director for Clinical Research Administration Office of Clinical Research – School of Medicine.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
Research Studies GOTCHA’S By Sally Duffy. Failure to follow protocol, investigator agreements and regulations Did not use device/drug in manner specified.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Essential Documents and Regulatory Files Lack of planning can constitute an emergency Rachel Sheppard Regulatory Director, OCRSS.
Study Closure Process Entropy is not a method Rachel Sheppard Regulatory Director, OCRSS.
JCRI Business Operations – Post-Award. Processes relating to the collection of sponsored clinical trial funding.
Getting a study done at Jefferson:. Startup Activities: Image courtesy of CITI Program Clinical Research Coordinator course.
Subject Screening, Recruitment, and Retention
Sponsor Visits and Monitoring
Slide 1 Outgoing Subawards Financial Process Tips.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
IP Accountability in Outpatient Clinical Trials Jessica Rinaldi, CCRP Farber Institute for Neurosciences.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
ClinCard System: Medical University of South Carolina
Clinical Trial Budgets
Is a Clinical Trial Right for Me?
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
The Role and Responsibilities of the Clinical Research Coordinator
Study Feasibility and Start-up
MAINTAINING THE INVESTIGATOR’S SITE FILE
Clinical Trials – Industry Sponsored Budgets
HOW TO ENTER BASELINE DATA
Alyssa Speier, MS, CIP November 13, 2013
Invoices to Sponsor in the CRC role
Structure of Industry Budgets
Elements of an Organized Regulatory Binder
Basics of Building and Understanding Data Collection Forms
ARCADIA Coordinator Webinar
Clinical Trials Budgeting
Getting a Study Done at Jefferson:
Clinical Trials Budgeting, Part 2
HOW TO ENTER BASELINE DATA
HOW TO SCREEN PATIENTS AND BOOK THE BASELINE VISIT APPOINTMENT?
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Clinical Trial Budgets
Clinical Trial Budgets
Central IRB Components of ARCADIA
Presentation transcript:

PRCSG Training Webinar: Budget for Industry Sponsored Studies Anne Johnson, Senior Specialist-Project Management Cincinnati Children’s Hospital Call in: 1-866-629-4752 Passcode 502017#

Outline Start up costs overview Comparative start up costs – 3 clinical trials Routine study visit costs Conclusion

Start up costs (1) IRB fees Average initial submission for a local IRB $3500 Average fee per amendment approval $1250 Average fee for continuing review $2000 The initial submission fee and the time/labor costs needed for the submission packet to be completed are usually included in the start up costs provided before the study starts. The amendment and annual review fees usually have to be invoiced separately as they occur.

Start up costs (2) Pharmacy fees Average start up fees for investigation pharmacy are $3,500. Every visit usually incurs an additional dispensing fee. Check with your pharmacy about fees for drug reconciliation and policies for return of used and unused drug at every study visit. Pharmacy staff should take care of their own delegation log and study forms for drug receipt, dispensing, reconciliation, and destruction.

Start up costs (3) Administrative start up fee can range from 5-10K depending on the sponsor. Regulatory coordinator time to collect and file necessary “reg docs” (1572, delegation log, CVs, licenses, HSP training, financial forms) Time needed to write consents per site and sponsor templates, IRB submission documents Training followup for protocol, IB, pharmacy manual for all staff listed on the delegation log

Start up costs (4) Will you use a clinical trial research center? Costs and time for application. Sometimes the CTRC requires a protocol application in addition to the IRB submission. The hourly costs for CTRC use can either be under your “other costs” section of the contract (need to be invoiced) or included in the patient per visit costs.

“Other costs” Some contracts will offer close out fees as well as start up fees. Check your contract for other costs that must be invoiced to collect payment. Screen failures pK sampling if not included in the patient visit costs

Comparative start up costs by sponsor Local IRB fees $3,500 actual $4,000 IRB amendment fee $1,250 IRB annual review $2,000 Admin start up $10,385 $12,750 $6,500 IRB document prep none $1,200 Pharmacy start up $2,500 Lab set up $550 Screen fails $921 $1,619 Close out fee Additional samples $40 $300 $95 Record retention $1,360 Total start up costs $20,596 $20,660 $12,214

Routine study visit costs Schedule of events should be broken down by visit in the contract to show what needs to be done when and how much the sponsor will pay for the activity. These costs are usually paid directly once the visits are completed and entered into the EDC. No invoice is needed to collect these payments. It is a good idea to double check these activities with your clinic practice procedures. Most hospitals require a breakdown of research vs. standard of care charges for study visits.

Routine study visit typical costs (1) Informed consent/parent permission/assent and complete medical history $150-$200 Uveitis assessment (slit lamp exam) $100 Complete physical exam (baseline and pivotal time points) $300-$400 Partial physical exam (other time points) $250 Tanner stage (usually done twice-baseline and last visit) $75-$100 Quantiferon-TB (blood test) done at baseline or screening visit and possibly yearly $75-$100

Routine study visit typical costs (2) Complete joint evaluation by certified assessor (sometimes blinded depending on protocol) $75-$125 Physician Global Evaluation of Overall Disease Activity $50-$75 Subject Reported Outcomes CHAQ CHQ PedsQL Pain and global evaluations $35-$50

Routine study visit typical costs (3) ESR or CRP (marker of inflammation)- this could be onsite testing or collection and shipping to central lab, prices vary by process $25-$50 Sample collection, processing, and shipping for central lab $50-$80 Study Treatment management Review patient diary, answer questions Collect used/unused IP, reconciliation records Pharmacy orders and returning used/unused IP Dispense new IP to patient $85-$100

Routine study visit typical costs (4) Study Treatment management (continued) If IP is by injection, some protocols require that the subject administer while in clinic and then wait 30 minutes for repeat vitals If IP is by infusion, this extra cost for CTRC or infusion center might be included in the visit charge or might be listed under “other costs”. Make sure the cost of the infusion is listed somewhere in the contract. Typical infusions take 30-60 minutes and then need repeat vitals.

Routine study visit typical costs (5) Study Coordinator Fees Confirming eligibility criteria with PI Consenting procedures Prior/concomitant meds Vital signs, height, weight, possible repeat vitals after IP administration will be needed Randomization Submitting assessments to PRCSG for some studies and some visits AE/SAE review, monitoring with PI $150-$200

Routine study visit typical costs (6) Data entry into EDC $100-$150 Subject/caregiver travel reimbursement (depends on protocol and time spent on site) $50-$100 PK sampling might be part of protocol $40-$50 Urine or blood pregnancy tests for WOCBP, depending on protocol, every time new IP is given or as requested by sponsor $50

Routine study visit typical costs (7) Total costs should be listed per visit and then per patient Costs should be listed with and without overhead

Conclusion Repeat webex September 13, 11am Questions? Comments? Proposed topics for future webex training? prcsg@cchmc.org